National Defense And Chemical Engineering

Healthcare Prof:

School children who consume foods purchased in vending machines are far more most likely to create poor diet high quality – and that could be associated with getting overweight, obese or at danger for chronic health difficulties like diabetes and coronary artery illness, according to investigation from the University of Michigan Medical School.

The study also looked at foods sold in school stores, snack bars along with other associated sales that compete with USDA lunch plan offerings and located that these pose exactly the same well being and diet risks in school-aged children.

“The foods that children are exposed to early on in life influence the pattern for their eating habits as adults,” says lead study author Madhuri Kakarala, M.D., Ph.D., clinical lecturer of internal medicine in the U-M Medical School.

Previous studies assessing the nutritional value of school lunches as well as the impact they have on children’s overall health have found similar outcomes, but this study is the very first to look specifically at competitive foods and beverages – those sold at snack bars or vending machines, rather than through the USDA lunch plan.

Researchers analyzed information from two,309 children in grades 1 via 12 from schools across the country. Interviewers administered questionnaires to obtain 24-hour food intake data on a given school day. Second-day food intake information was obtained from a group of students to account for day-to-day usual intakes.

Among those surveyed, 22 percent of school children consumed competitive or vended food items in a school day. Usage was highest in high school, exactly where 88 percent of schools had vending machines, compared to 52 percent of middle schools and 16 percent of elementary schools. Competitive food and beverage consumers had drastically higher sugar intakes and lower dietary fiber, vitamin B levels and iron intakes than non-consumers.

Soft drinks accounted for more than two-thirds of beverages offered in school vending machines and stores. Desserts and fried snacks were essentially the most commonly consumed vended items amongst elementary school children and beverages other than milk and fruit juice had been the most commonly consumed items amongst middle and high school students. Other regularly consumed vended foods included candy, snack chips, crackers, cookies, cakes and ice cream.

The results did not show a considerable distinction in students’ consumption of these items based on family income or race and ethnicity.

Findings of this study appear inside the September issue of the Journal of School Well being.

“Consumption of vended foods and beverages currently offered in U.S. schools is detrimental to children’s diet high quality,” says Kakarala. “Childhood obesity, resulting from poor dietary choices, like those identified in this study, greatly increases the risk for many chronic diseases. A healthy school food environment can reduce these dietary risks.”

Based on their findings, the study authors advocate school administrators design guidelines restricting vended and competitive foods and beverages to those which are rich with nutrients and not energy-dense. In addition, school foodservice personnel can prepare point-of-service materials and displays to promote much more healthful foods for example fresh fruit, yogurt, low-fat milk, juice and sandwiches.

“Targeted nutrition education to promote the importance of healthful snacks is further stressed by the Child Nutrition Act – the key federal legislation that determines school food policy and resources,” Kakarala says. “These as well as other types of school-enforced policies could be really helpful for children in generating smarter consuming choices all through the school day.”

If more healthful snack possibilities are not obtainable in vending machines or school stores, children are at danger for poor nutrition by choosing these items over a USDA-choice lunch or perhaps a meal packed from home, Kakarala says.

Additional authors:
Debra R. Keast, Ph.D., of the Food & Nutrition Database Investigation, Inc. and Sharon Hoerr, Ph.D., R.D., of the Michigan State University Department of Food Science and Human Nutrition

Reference:
Journal of School Wellness, Vol. 80, No. 9, September 2010

Source: University of Michigan Wellness Method

Copyright: Medical News Today
Not to be reproduced without having permission of Medical News These days

Healthcare Prof:

5 (1 votes)

In a very first person paper published in the August 27, 2010 issue of Childhood Obesity, Dr. Melinda Sothern, Director of Health Promotion and Professor of Public Health at LSU Well being Sciences Center New Orleans, supplies 3 ways to de-program the 1950s obesity trinity underlying the current obesity epidemic inside the United States and protect future generations from its health consequences.

“The combination of prenatal tobacco use, infant formula, and frequent pregnancies – i.e., the obesity trinity – synergistically created the first generation of nutritionally programmed youth, the baby-boomers,” writes Dr. Sothern. “Suburban living, value-priced fast food, cable TV, and computers sealed their fate. Now in their 50s and 60s, this generation has the highest prevalence of obesity in history, triple that of their parents. Of far more concern are their obese children, a lot of programmed due to maternal obesity and gestational diabetes.”

Dr. Sothern is most concerned about the vulnerability of the grandchildren of baby-boomers.

“These are the preschoolers with substantial obesity, the 6-year-olds with metabolic syndrome along with the obese adolescents with hypertension, kind 2 diabetes or non-alcoholic fatty liver disease, so resistant to therapy that the only answer could be bariatric surgery,” notes Dr. Sothern. “More alarming are the severely obese, insulin-resistant teenage girls who will ultimately provide the optimal fetal environment for the next generation of metabolically programmed newborns.”

Dr. Sothern believes that efforts ought to focus on three opportunities for change – in the beginning of pregnancy, prior to puberty when metabolism could most likely be set for life, and within the years leading as much as motherhood. She advises that: intense nutrition and physical activity behavioral counseling begin at the initial obstetrical visit and continue until the child enters preschool preschoolers be provided opportunities at home, in school, and all through the community to engage in free play most of their waking hours, offered appropriately portioned, nutrient dense foods in designated locations away from media distractions high quality weight-management programs with intense behavioral counseling be obtainable to families with already obese youth.Dr. Sothern’s study is widely published in a multitude of peer-reviewed scientific journals and she will be the author of The Handbook of Pediatric Obesity: Clinical Management along with the Handbook of Pediatric Obesity: Etiology, Pathophysiology and Prevention. She is also the senior author of a popular press book for parents to use in conjunction with their pediatrician or family physician entitled Trim Kids (2001, Harper Collins). The Trim Kids program is recognized by the National Cancer Institute as a Research Tested Intervention Plan and was acknowledged by a U. S. Surgeon General for its community dissemination in YMCA centers in Louisiana. Dr. Sothern was the 2009 recipient of the Obesity Society’s Oded Bar Or Award for Excellence in Pediatric Obesity Analysis. She co-founded the Louisiana Childhood Obesity Investigation Consortium and at the moment serves as its Chairman. Dr. Sothern is also the Principal Investigator on two National Institute of Health (NIH)-sponsored studies.

The full paper is accessible on-line here.

Source:
Leslie Capo
Louisiana State University Well being Sciences Center

three.5 (4 votes)

Healthcare Prof:

5 (1 votes)

Article Opinions:2 posts
There is critical concern about top-selling diabetes drug rosiglitazone (Avandia), its safety, together with the whole method by which medicines are regulated, evaluated and promoted worldwide, based on a BMJ (British Medical Journal) investigation. Dr. Fiona Godlee, BMJ Editor-in-Chief, thinks Avandia really should not have been licensed; she believes it should be withdrawn.

There needs to be greater access to raw data utilized to license drugs, in addition to a lot more robust regulatory processes, to enable examination by the scientific community, Godlee added.

The investigative write-up reveals that the Commission on Human Medicines advised the Medicines and Healthcare products Regulatory Agency (MHRA), the UK’s regulatory body for drugs, to withdraw the drug due to the fact “risks of rosiglitazone outweigh its benefits..it no longer has a place on the UK market”.

Doctors within the UK are at the moment advising that new patients ought to not be started on rosiglitazone, and those already on the medication needs to be reviewed so that alternative therapies could be deemed. Patients at higher danger of heart illness are becoming advised to cease taking the medication.

The FDA (Food and Drug Administration, USA) approved rosiglitazone in 1999, even though the EMA (European Medicines Agency) did the same in 2000, to help lower blood sugar in type 2 diabetes patients.

Since those two approvals, a number of studies have linked rosiglitazone to a tiny overall enhance in heart attack danger. Nevertheless, in July 2010 the Scientific Advisory Committee, which advises the FDA, said that it was safe sufficient to remain on the market. The Committee’s recommendations are not binding, but the FDA generally goes along with what it says.

Dr. Deborah Cohen, investigations editor of the BMJ, obtained data under the Freedom of Info Act that note “a paucity of evidence during the European approval approach and outline concerns from some panel members about the long term risks and positive aspects of rosiglitazone.”

Several specialists have given that commented on the poor evidence base, along with really little long-term details on the drug’s cardiovascular safety.

The reports also comments on the quality of information utilised by GlaxoSmithKline, the makers of Avandia (rosiglitazone), to demonstrate that the drug didn’t result in elevated heart troubles compared to other diabetes medications. Concern is also expressed regarding the lack of publicly accessible trial results for independent scientific scrutiny, a lack of transparency within the European method, along with the ability of the European regulator to assess individual patient information.

The report highlights pressures on regulatory agencies by diabetes specialist doctors to approve rosiglitazone, and agency failure to act swiftly on emerging safety information.
,br>Two professionals comment on today’s report.

Professor Nick Freemantle, University of Birmingham, believes an overhaul inside the standards of regulatory trials to minimize the chances of a similar situation occurring in other clinical locations inside the future is needed:

In order to learn from our mistakes, we should increase the top quality of safety information from clinical trials on all new well being care interventions, not just antidiabetic drugs.

Professor John S.Yudkin, University College London, says that doctors must concentrate far more on what matters to patients:

Ten years after the release of rosiglitazone, we still cannot accurately quantify the harm to which we were exposing our patients.

Prof. Freemantle accepts that some blame should lie with clinicians for not insisting on much better proof of long-term benefit. He adds:

We require to be absolutely certain that our lengthy term treatments for form 2 diabetes are not causing the very harm they are meant to prevent. And if the regulatory bodies do not insist on clear evidence of higher benefit than harm, they are failing in their simple purpose.

Feature – Drug Regulation
“Rosiglitazone: what went wrong?”
Deborah Cohen
BMJ 2010; 341:c4848. doi: 10.1136/bmj.c4848

Written by Christian Nordqvist

View drug information on Avandia.
Copyright: Medical News Today
Not to be reproduced without having permission of Medical News Today

four (1 votes)

Healthcare Prof:

4 (two votes)

One of the most ambitious large-scale projects in Human Genetics has been launched: Epitwin will capture the subtle epigenetic signatures that mark the differences between five,000 twins on a scale and depth never before attempted, providing key therapeutic targets for the development of drug treatments.

The project is really a collaboration among TwinsUK, a leading twin research group based at King’s College London, and BGI, among the world’s largest genomic organisations headquartered in Shenzhen, China. Epigenetics could be the most cutting edge emerging field in Genetics, which explores how the actions of genes can be temporarily modified by chemical reactions that might happen either at random or by lifestyle or diet. This effect may last several generations.

The plan would be to look in the methylation patterns of 20 million sites (referred to as CpG islands) in the DNA of every twin and compare them with the patterns in the co-twin. Instead of looking at similarities as in prior studies, the team will be looking for differences that explain why several identical twins don’t develop exactly the same diseases. Initially the team will focus on obesity, diabetes, allergies, heart illness, osteoporosis and longevity, but the method may be applied to every common trait or illness.

‘Finding the crucial differences between twins will lead us towards the important genes that are being turned on and off, and so to the trigger of disease, with great potential to come across key targets for drug treatments,’ says Tim Spector, Director of TwinsUK and Professor of Genetic Epidemiology at King’s College London, who is leading the project. ‘The fact that twins are such a marvellous natural experiment, combined using the hundreds of disease particulars and traits on the twins that we have collected more than 17 years, offer a unique study chance. So far this kind of study has only been attempted on a handful of twins, so we want to scale it up – 1 thousand fold.’

The Executive Director of BGI, Professor Jun Wang, whose team completed the sequencing of numerous diverse species, which includes an Asian individual, the Giant Panda, the rice genome, the silkworm genome, and the genomes of the cucumber and ant, is excited about the study: ‘Epigenetics is one of our significant targets for the next five years – and this mixture of our technology and resources with the unique twin resource will supply the globe with an unprecedented dataset. We hope to unlock a lot of secrets about human genetics that we don’t at present understand, and to accelerate research and applications in human healthcare.’

Notes:

The project is expected to price about ????20 million ($30 million). These expenses are getting shared by the groups, and supported by a Senior Investigator award to Professor Spector for the Epitwin project by the European Investigation Council.

The Department of Twin Investigation and Genetic Epidemiology at King’s College London

King’s College London’s Department of Twin Research and Genetic Epidemiology (DTR) encompasses the biggest UK adult twin registry of 11,000 twins utilized to study the genetic and environmental aetiology of age related complex traits and diseases. The DTR has been among the significant departments of King’s Division of Genetics and Molecular Medicine because 2006 with a team of more than 40 staff.

The Department has a voluntary database of 10,000 identical and non-identical, mostly female, twins from across the UK among the ages of 16 and 85 years – with a mean age of 48. It’s now the UK’s only adult twin registry and is the most detailed clinical adult register within the globe.

DTR has an international track record of analysis into the genetics of complicated illnesses with a certain focus on age-related illnesses. Its existing main focus may be the genetics of metabolic syndrome and cardiovascular illness, the musculoskeletal method and ageing together with investigation into sight and miscellaneous locations for example skin illness, immunology, gastroenterology and behaviour.

Source:
Melanie Haberstroh
King’s College London

5 (three votes)

Healthcare Prof:

People who sleep much less than six hours a night could possibly be 3 occasions more most likely to develop a condition which results in diabetes and heart disease, based on researchers in the University of Warwick.

A study by a team of researchers from Warwick Medical School as well as the State University of New York at Buffalo has discovered short sleep duration is related to an elevated risk of a pre-diabetic state, known as incident-impaired fasting glycaemia (IFG).

IFG implies that your body isn’t able to regulate glucose as efficiently as it really should. Men and women with IFG have a higher risk of developing kind two diabetes and are at an elevated danger of heart disease and stroke.

The study has just been published within the Annals of Epidemiology journal. The researchers looked at six years of information from 1,455 participants in the Western New York Health Study.

All participants had been aged in between 35 and 79 years old and all completed a clinical examination that included measures of resting blood pressure, height and weight. They also completed questionnaires about their general well being and wellbeing and sleeping patterns.

Lead author at Warwick Medical School Dr Saverio Stranges said: “We identified that short sleep, less than six hours, was related to a considerable, three-fold increased likelihood of developing IFG, compared to men and women who got an average of six to eight hours sleep a night.”

This study could be the very first to look at the association between sleep duration and IFG. Dr Stranges stated there had been quite a few ways in which sleep loss could result in disordered glucose metabolism.

He stated: “Previous studies have shown that short sleep duration results in a 28% boost in mean levels of the appetite stimulating hormone ghrelin so it can impact feeding behaviours. Other studies have also shown that a lack of sleep can decrease glucose tolerance and increases the production of cortisol, a hormone produced in response to stress.”

“More analysis is needed but our study does suggest a very strong correlation in between lack of sleep and type 2 diabetes and heart illness.”

Professor Francesco Cappuccio, Head of the Sleep, Wellness & Society Programme at the University of Warwick said: “These results are welcome and confirm our early reports that both sleep quantity and top quality are strong predictors of the development of sort two diabetes, strokes and heart attacks”.

Sources: Warwick University, AlphaGalileo Foundation.

Healthcare Prof:

Article Opinions:1 posts
HHS’ Agency for Healthcare Research and High quality nowadays released a series of free evidence-based guides designed to help Spanish speakers understand and compare the risks, positive aspects and side effects of treatments for eight wellness conditions.

The guides supply valuable details that patients can use in talking with their clinicians. Half of the topics cover well being troubles particularly for women, including guides on controlling gestational diabetes during pregnancy, deciding to induce labor and comparing core needle biopsy to surgical biopsy for breast lesions. Other guides cover treatments for high cholesterol, osteoarthritis of the knee as well as the use of insulin analogues for treating form 2 diabetes.

“Many Spanish speakers don’t have access to credible, easy-to-understand details about wellness care conditions and their remedy alternatives, and that may be a considerable barrier to seeking medical care,” stated Carolyn M. Clancy, M.D., AHRQ director. “These guides represent crucial resources that will help encourage patients to seek care and function with their physicians to discuss all of their therapy choices.”

Dr. Clancy added that AHRQ’s 2009 National Healthcare Disparities Report shows that whilst the quality of health care is slowly improving for the nation as a whole, for many measures the report tracks, it truly is getting worse for Hispanics.

The new publications are portion of AHRQ’s growing inventory of plain-language, English and Spanish guides that summarize the scientific evidence on various well being conditions so that consumers can learn much more concerning the effectiveness and danger of diverse remedy possibilities.

The guides are produced by AHRQ’s Efficient Wellness Care Program, a leading federal effort to conduct comparative effectiveness analysis. That program, authorized by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, represents an critical federal effort to compare treatments for wellness conditions and make the findings public. The plan is intended to assist patients, doctors, nurses, pharmacists and others select probably the most successful treatments for individual patients.

The titles of the eight guides are:

- Insulina premezclada para la diabetes tipo two. Gu???aa para adultos (Premixed Insulin for Type 2 Diabetes: A Guide for Adults);

- Tratamientos para el cholesterol alto. Gu???aa para adultos (Treating High Cholesterol: A Guide for Adults);

- Osteoartritis de la rodilla. Gu???aa para adultos (Osteoarthritis of the Knee: A Guide for Adults);

- Diabetes gestacional. Gu???aa para la mujer embarazada (Gestational Diabetes: A Guide for Pregnant Women);

- Cuando se tiene una biopsia del seno. Gu???aa para las mujeres y sus familias (Getting a Breast Biopsy: A Guide for Women and Their Families);

- Ablaci????n con radiofrecuencia para tratar la fibrilaci????n auricular. Gu???aa para adultos (Radiofrequency Ablation for Atrial Fibrillation: A Guide for Adults);

- Reduzca el riesgo de c??????ncer del seno con medicamentos. Gu???aa para la mujer (Reducing the Risk of Breast Cancer With Medicine: A Guide for Women); and

- ?Est?????? pensando que le induzcan el parto? Gu???aa para la mujer embarazada (Thinking About Having Your Labor Induced? A Guide for Pregnant Women).

In addition to the new guides, AHRQ previously released Spanish-language guides on nine other topics, which includes oral medicines for type two diabetes, discomfort medicines for osteoarthritis, medications for adults with depression and treatments for osteoporosis and prostate cancer.

To access all of AHRQ’s Spanish-language comparative effectiveness guides for patients and consumers, go here. For AHRQ’s entire inventory of free Spanish-language consumer wellness details products, go here.

Source:
AHRQ

five (1 votes)

Healthcare Prof:

Article Opinions:1 posts
A comprehensive new survey of all 152 PCTs undertaken and published by the Medical Technology Group (MTG), backed by national diabetes support groups INPUT, the Juvenile Diabetes Research Foundation (JDRF), clinicians and leading cross-party MPs, has exposed significant inequities in care for patients with diabetes across the country. The findings show that 17% of patients with type 1 diabetes in Blackburn with Darwen PCT benefit from insulin pump therapy, compared with only 0.4% in Luton, leaving tens of thousands of patients with type 1 diabetes with no access to the right remedy from the NHS.

The MTG may be the UK’s leading coalition of patient groups, investigation charities and medical device manufacturers working to enhance access to price useful medical technologies. The survey, launched as portion of the MTG’s ‘Pump Action’ campaign confirmed that overall uptake and utilisation for insulin pump therapy remains extremely low, just a third of the Good benchmark for the therapy.

The MTG conducted the survey to facilitate much better understanding of the causes of this problem, which persists regardless of years of government study and established guidance which recommends higher utilisation of insulin pumps. The survey discovered that:

– The average rate of insulin pump provision for folks with form 1 diabetes is three.9% compared to the 12% benchmark recommended by NICE[1];

– Only two PCTs gave info which suggests they are providing insulin pumps in line using the Nice benchmark;

– Only five out of 113 PCTs have a strategy in place to implement Nice guidance on insulin pumps in line with their statutory duty to adhere to Good technology appraisals inside three months of issue;

– Just over a third (35%) of PCTs don’t use tools and guidance including NICE’s Commissioning Guide to assist deliver adequate insulin pump therapy services;

– Current utilisation of insulin pumps for kind 1 diabetes in the UK (3.9%) is extremely low in comparison to other countries, for example the US (estimated at 35%) and Sweden, France and Germany (estimated at 15-20%)[2].

The MTG is calling on the Coalition government to make positive adjustments to assist improve the wellness, safety and well-being of the UK’s quarter of a million diabetics – and in the same time make essential efficiency savings for the NHS.

Insulin pump therapy can be a clinically and expense effective treatment alternative that’s recommended by Good for folks with sort 1 diabetes, whether adult or child, for whom multiple every day injections have failed, and for children under 12 if multiple daily injections are not deemed practical or proper

The principal rewards of insulin pump therapy for patients and also the NHS are as follows:

– improved patient outcomes which includes management of blood glucose levels (HbA1c) which reduces the danger of severe hypoglycaemia (symptoms of severe hypoglycaemia include collapse and coma) and/or diabetic ketoacidosis (DKA);

– Decreased threat of complications (e.g. heart illness, stroke, blindness, kidney disease, nerve damage);

– General much better wellness, improved treatment satisfaction, decreased anxiety and depression and improved quality of life;

– A reduction in emergency hospital admissions;

– A reduction in planned hospital admissions. Far better diabetes self-management is linked to a reduction in inpatient supportive care and overall hospital stays and associated NHS costs[3].

Here is just 1 example of the challenging struggle which is typically endured by patients who are trying to get insulin pump therapy from the NHS:

Thomas Double is 12 and has sort 1 diabetes. He uses an insulin pump to manage his condition, after his mother Jacqui battled for over two years to get agreement from her PCT to fund the therapy. His brother Joseph (14) also now uses an insulin pump which gives him superb control of his own blood insulin levels along with the freedom to get on at school and enjoy time with friends.

Jacqui Double, mother of Thomas and Joseph, stated:

‘It’s a travesty that PCTs nonetheless aren’t providing insulin pumps to those eligible under Good guidance – parents and individuals shouldn’t have to battle with NHS decision-makers in order to get the services and support they’re entitled to.’

Adrian Sanders MP, Chair of the All Party Group on Diabetes stated:

“It is sad to see that following years of investment and promises from Government, we’re nonetheless seeing glaring postcode lotteries in the health service. The lives of so many individuals with diabetes might be easily improved by providing pump therapy even though for the taxpayer you’ll find lengthy term savings, not merely inside the NHS. The UK ought to be leading the world in pump therapy, not lagging behind most of Europe as well as the Western globe.”

Dr Ian Gallen, Secretary of the Association of British Clinical Diabetologists said:

“I welcome the MTG’s campaign to increase patient access to insulin pumps. The introduction of pumps some two decades ago was a major advance in the management of type 1 diabetes which has transformed patients outcomes and experiences – but uptake is nicely below par and we need concerted action to bring the rewards of pumps to the majority of patients not just the lucky couple of.”

The MTG urges PCTs and emerging GP consortia to access as an urgent priority the “How to Why to” Guide on Insulin Pumps, which has been produced and recently launched by the NHS Technology Adoption Centre (NTAC) following its national programme to identify and overcome the barriers associated with implementing this technology.

The new guide has been particularly designed to save commissioners time, boost patient outcomes and improve overall productivity. The guide helps to bridge numerous of the gaps identified by Trusts, PCTs along with other stakeholders who play a crucial role in delivering diabetes services as part of NTAC’s implementation project by providing:

– Support for the development of a business case for the provision of insulin pump therapy in line with Nice guidance;

– A roadmap to implementation of a pump service including how to set up an implementation team;

– Guidance on how to effectively procure pump therapy technologies and associated consumables.

NTAC’s Hadleigh Stollar stated:

“The “How to Why to” guide incorporates NTAC’s national experience of systematically implementing insulin pump therapy to enable successful alter to be achieved locally. Commissioners are in the heart of an ambitious agenda of change in today’s NHS – we appear to them to drive improved high quality services and to meet outputs that will deliver high top quality care for patients. This is a stiff challenge, but the “How to Why to” guide is particularly designed to help commissioners and all those who play an critical role in delivering useful diabetes care, to understand what it takes to plan and deliver an appropriate insulin pump service that’s cost efficient, and improves the experiences and outcomes of patients wherever they live.”

In addition the MTG makes the following recommendations to enhance insulin pump uptake:

1. Diabetes patients needs to be given better info about their remedy options, such as insulin pumps. Clinicians ought to routinely share high quality data with their patient, and information should also be readily available on-line and by way of printed supplies. This will assist patients to make appropriate choices about their care.

two. A comprehensive map of insulin pump services, such as specialist pump clinics, ought to be produced available to GPs, and patients ought to be in a position to access specialist pump centres via the Decide on and Book system. This will support GPs in their new commissioning role to make sure that patients can access the care they need to have in line with Nice guidance.

three. The new Nice good quality standard on top quality standard ought to support improved access to insulin pump therapy as one of the standard range of treatment options for individuals with type 1 diabetes.

four. Training and guidance on the use of insulin pumps needs to be readily accessible to both patients and clinicians to prevent unnecessary delays to provision:

Structured training modules should be created readily available to patients online to make certain safe and timely access to insulin pumps.

Insulin pump modules needs to be included inside GP and secondary care training.

five. Patients’ rights enshrined inside the NHS Constitution to NICE-approved treatments such as insulin pumps should be produced legally enforceable. Healthcare commissioners ought to take steps to make sure that patients in their nearby region have handy access to high top quality specialist insulin pump services that meet their clinical needs.

John Davis, Founder of INPUT and member of the MTG Management Committee said:

“Access to a therapy as critical as insulin pumps should not be dependent on exactly where you live. Insulin pumps have been suggested by Good because they are an efficient use of the NHS’s resources, and simply because they can have a dramatic impact on patients’ quality of life and clinical outcomes.

“The MTG is campaigning to enhance patient access to insulin pumps by ensuring that every individual with sort 1 diabetes who could benefit from an insulin pump – no matter exactly where they live – receives the specialist care they need”.

Notes

– Interviews could be arranged with patients and spokespeople on request.

– The MTG is really a coalition of patient groups, study charities and medical device manufacturers working to improve access to expense effective medical technologies for everyone who requirements them.

– INPUT is a national advocacy group working to improve access to insulin pump therapy. INPUT can be a member of the MTG.

– The survey has been undertaken by the MTG, in partnership with INPUT and Adrian Sanders MP, chair of the All Party Group on Diabetes.

– All 152 PCTs in England had been asked for particulars of insulin pump provision in their area, and also the services and procedures which they have in place to care for diabetics. The study was carried out from January – Could 2010.

– Less than 4% of patients with sort 1 diabetes have access to an insulin pump in the UK, compared with 35% in the US

– Nice guidance states that continuous subcutaneous insulin infusion (CSII) is advised for individuals with kind 1 diabetes, whether adult or child, for whom multiple daily injections have failed, and for children under 12 if multiple day-to-day injections aren’t deemed practical or appropriate.[4]

– Good guide: Commissioning an Insulin Pump Therapy Service

1. NICE’s commissioning guide on insulin pump therapy services states that the standard benchmark rate for the uptake of insulin pump therapy is 12% of folks with Kind 1 diabetes. It truly is 33% for children younger than 12 years old.

two. Pickup J. Insulin pump therapy: then and now. In: Pickup J. Insulin Pump Therapy and Continuous Glucose Monitoring (ed), pp 1-10. Oxford University Press, Oxford, 2009

3. NHS Technology Adoption Centre

4. Nice Technologies Appraisal Guidance 151

Source:
Medical Technology Group

5 (1 votes)

Healthcare Prof:

Researchers in the Buck Institute for Age Investigation have discovered a novel way in which insulin affects cell metabolism and cell survival. Surprisingly the insulin signaling pathway, which is involved in aging, diabetes and stress response, is active at a deeper degree of cell activity than scientists expected. The study appears inside the September 8th issue of Cell Metabolism.

Insulin is vitally involved in a lot of cell functions. Buck Institute faculty and lead author Gordon Lithgow, PhD, says scientists have known for years that insulin is involved in the level of cell activity known as transcription, where DNA produces RNA. Lithgow said the new analysis, within the nematode worm C. elegans, revealed that insulin is also active in the level known as translation, where RNA specifies protein synthesis.

Lithgow says the discovery of this new degree of regulation opens a host of opportunities. “We are desperate to understand why aging can be a risk factor for illness, we want to know why diabetes is related to aging,” stated Lithgow. “Here we have a insulin signaling pathway involved in aging, diabetes and stress response. This gives us far more precise avenues to explore how we might intervene in illness,” he said.

Using long-lived mutant worms, researchers demonstrated that elevated tolerance to stress, on account of lower insulin signaling, just isn’t dependent on stress-induced responses in the degree of transcription, but rather needs active protein translation.

Lithgow says the investigation fits in with function getting completed inside the Buck Institute laboratories of Brian Kennedy and Pankaj Kapahi, all of which point to the importance of translation. Lithgow, who directs the Institute’s Geroscience program, says the research will lead to new collaborations. “This work highlights the importance of protein homeostasis – the maintenance of metabolic equilibrium,” stated Lithgow. “What proteins are created inside the cell? When are they made? How and when are they gotten rid of? What happens when they are damaged?” Lithgow thinks control of protein homeostasis is important for healthy aging and is intrinsically involved in illnesses such as Parkinson’s and Alzheimer’s where protein homeostasis seems to get muddled up. “It’s about connections,” stated Lithgow, “Now we need to have to connect with what is known about insulin signaling in diabetes with various disease states; we need to know how this tiny component of cell metabolism fits into the bigger picture of aging and disease.”

Other contributors towards the work:
Other Buck Institute researchers involved inside the study contain Aric N. Rogers, Silvestre Alavez, Alan E. Hubbard, Simon Melov and Pankaj Kapahi. Contributors consist of Gawain McColl and Ashley I. Bush from the Mental Wellness Investigation Institute, Parkville, Victoria, Australia; and Christopher D. Link, Institute for Behavioral Genetics, University of Colorado, Boulder. The study was supported by grants from The Glenn Foundation for Medical Study, The Herbert Simon Foundation, American Foundation for Aging Investigation, The Larry L. Hillblom Foundation, and the National Institutes of Health.

Source:
Kris Rebillot
Buck Institute for Age Research

Healthcare Prof:

Obese women who have bariatric surgical procedures before pregnancy had been 3 occasions much less most likely to create gestational diabetes (GDM) than women who have bariatric operations after delivery, based on new study findings published within the August issue of the Journal of the American College of Surgeons. The retrospective study also discovered that delivery after bariatric procedures was related to reduced odds of cesarean section – an outcome related to GDM.

Gestational diabetes affects at least seven percent of all pregnancies in the United States, with rates as high as 14 percent amongst particular populations. Its prevalence is growing among reproductive-age women, parallel to increasing rates of obesity and kind two diabetes. Currently, 33 percent of women more than 19 years of age meet the criteria for obesity (body mass index [BMI] > 30 kg/m2) and seven percent for extreme obesity (BMI > 40 kg/m2). Bariatric surgical procedures are the only intervention shown to produce sustained weight reduction in the vast majority of subjects.

“The key finding of our study is that women who had bariatric surgery before they delivered reduced odds of gestational diabetes when compared with women had bariatric surgery soon after they delivered,” stated Anne E. Burke, MD, MPH, assistant professor of obstetrics and gynecology at the Johns Hopkins University School of Medicine in Baltimore, Md.

“Despite a growing body of evidence supporting the safety and efficacy of bariatric surgery in reversing obesity-related complications, couple of candidates for the procedure are referred to a surgeon to talk about their possibilities,” stated Martin Makary, MD, MPH, associate professor of surgery at Johns Hopkins University School of Medicine and senior author of the study.

Researchers performed a retrospective study to compare rates of GDM and related outcomes between a group of women who had bariatric operations before pregnancy (n=346) as well as a group who had bariatric operations soon after delivery (n=354) between 2002 and 2006. Women who delivered right after bariatric procedures had lower incidences of GDM (8 percent vs. 27 percent, odds ratio (OR) 0.23) and cesarean section (28 percent vs. 43 percent, OR 0.53) than those who delivered before bariatric procedures.

Women who delivered right after bariatric operations had been slightly older (32.five years vs. 31.1 years, p < 0.001). The median time from surgical procedure to delivery was 19.6 months, which meant that the majority of women did not adhere to the current recommendation to defer pregnancy for two years after bariatric procedures were performed. Deliveries before bariatric operations occurred at a median time of 16.5 months, meaning that most women waited more than a year after delivery before having bariatric procedures. The majority of women in each group had a bypass procedure (75 percent in the prebariatric delivery group and 87 percent in the postbariatric delivery group). Women who had a prebariatric delivery were more likely to have an adjustable banding procedure than women with a postbariatric delivery (9 percent vs. 3 percent).

Source:
Sally Garneski
Weber Shandwick Worldwide

five (1 votes)

Healthcare Prof:

The Committee for Medicinal Products for Human Use (CHMP) met on Wednesday 8 September to discuss the ongoing benefit-risk assessment of the rosiglitazone-containing medicines Avandia, Avandamet and Avaglim.The Committee discussed all of the obtainable information on the risk of cardiovascular issues related to rosiglitazone in order to prepare for its next scheduled meeting of 20-23 September 2010, when it expects to finalise its evaluation.

The CHMP identified a number of further questions that it really is putting towards the marketing authorisation holder, GlaxoSmithKline. The responses to these questions will support the Committee to reach its opinion on whether the marketing authorisations for rosiglitazone-containing medicines needs to be maintained, changed, suspended or revoked.The CHMP also discussed the available information on the feasible danger of narcolepsy with the influenza vaccine Pandemrix, in order to prepare for its plenary meeting later this month.

After the plenary meeting of 20-23 September, the Agency will publish the Committee’s conclusions.

Source:
European Medicines Agency

View drug info on Avandamet; Avandia.